Tonix制药控股 TNXP 深 沪
已收盘 09-12 16:00:00 美东时间
28.61
-2.600
-8.33%
华盛通- 最 高31.281
- 今 开30.51
- 成交量 68.50万股
- 最 低 28.5107
- 昨 收 31.21
- 总市值 53.47亿
- 52周最高 130.00
- 市盈率 静 --
- 换手率 0.37%
- 52周最低 6.76
- 委 比 71.55%
- 总股本 1.87亿
- 历史最高 13440000000.00
- 量 比 0.44
- 振 幅 8.88%
- 历史最低 15.00
- 每 手 1
- 风险率 5.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tonix Presents Clinical Data On Tonmya For Treatment Of Fibromyalgia At PAINWEEK Conference 2025; Phase 3 Data Support Q4 Launch Following PAINWEEK Showcase
Tonmya was approved by FDA on August 15, 2025 for the treatment of fibromyalgia and is the first new FDA approved treatment for fibromyalgia in over 15 yearsTwo pivotal Phase 3 studies demonstrated Tonmya significantly
09-08 19:04
Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025
Tonmya, a sublingual cyclobenzaprine HCl tablet, was approved by the FDA on August 15, 2025, as the first new treatment for fibromyalgia in over 15 years. Studies showed Tonmya significantly reduced pain, improved sleep, and decreased fatigue compared to placebo, with a favorable tolerability profile. It is expected to be available in the fourth quarter of 2025. Tonmya works by targeting sleep disturbances linked to fibromyalgia symptoms through ...
09-08 11:00
Tonix Pharma Faces Setback Despite FDA Approval
Tonix Pharma ( ($TNXP) ) has fallen by -14.34%. Read on to learn why. Tonix Pha...
08-30 22:03
美股周涨跌榜 | 回声星通信涨108.6%，AT&T斥资230亿美元收购特定无线频谱许可证；MONGODB涨44.1%，Q2业绩超预期
回声星通信涨108.6%，AT&T斥资230亿美元收购特定无线频谱许可证；MONGODB涨44.1%，Q2业绩超预期，大行纷纷上调其目标价>>
08-30 10:35
Tonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025
Tonix Pharmaceuticals Holding Corp. announced that its CEO, Seth Lederman, M.D., will participate in a fireside chat at the 2025 Cantor Global Healthcare Conference on September 4, 2025. The event will be webcast and available for replay. Tonix recently received FDA approval for Tonmya™, a first-in-class, non-opioid analgesic for fibromyalgia, marking over a decade since the last new treatment for the condition was approved. The company also mark...
08-28 11:00
Atlassian, CoreWeave, Duke Energy, Tonix Pharma, Dexcom: Insider Moves Unveiled!
Insiders have been trading these 5 stocks: (($TEAM)), (($CRWV)), (($DUK)), (($T...
08-23 21:01
美股周涨跌榜 | 鲍威尔“送利好”！MEME股OpenDoor周内暴涨58%；名创优品绩后连续两日大涨
鲍威尔“送利好”！OpenDoor周内暴涨58%，明星投资人称降息对公司非常重要；名创优品半年报亮眼，周内飙涨35%；蔚来全新ES8上市带动股价大涨31%>>
08-23 10:22
美股盘前 | 中概股走高，迅雷涨超15%；诺和诺德涨超3%，减肥药Wegovy获FDA批准用于治疗肝病
部分中概股走高，迅雷涨超15%，爱奇艺涨超9%；FFAI盘前涨超6%；诺和诺德涨超3%，减肥药Wegovy获FDA批准用于治疗肝病>>
08-18 16:16
美国FDA批准Tonix Pharmaceuticals用于治疗慢性病相关疼痛的药物
Tonix Pharmaceuticals Holding Co (TNXP)上周五表示，美国食品和药物管理局(FDA)已批准其用于治疗一种名为纤维肌痛（fi...
08-18 08:22
FDA Approves Tonix Pharma's Tonmya For Treatment Of Fibromyalgia In Adults
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 yearsFibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly womenTwo Pivotal
08-16 03:46
